The Valley Desk

ArticleFrontiers in oncologyPublished

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University. Affiliation source

Publication record

Type
Article
Venue
Frontiers in oncology
Published
Subject terms
Apoptosis; Cell cycle; Synergism; Cisplatin; Precision Medicine; Diffuse Pleural Mesothelioma (Dpm); Cyclin-dependent Kinases Inhibitors (Cdki)
PubMed ID
39011477
PubMed Central ID
PMC11246887
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal